News / 11 Aug 2022
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
News / 09 Aug 2022
Summit Therapeutics Closes Fully-Subscribed $100 Million Rights Offering
News / 02 Aug 2022
Summit Therapeutics’ Rights Offering Nearing Expiration Date
We are building a very differentiated company that focuses on bringing innovation to the treatment of high unmet medical needs by focusing on the cause of the condition and sparing the rest of the incredible ecosystem that is the human body. Precision-targeting agents will be the new standards of care because they benefit patients and healthcare providers by minimizing trauma while curing the disease, which, in turn, creates value for society and payers alike.
Chairman & Chief Executive Officer